AC Immune Ownership | Who Owns AC Immune?
AC Immune Ownership Summary
AC Immune is owned by 24.47% institutional investors, 38.09% insiders, and 37.43% retail investors. Bvf inc/il is the largest institutional shareholder, holding 20.09% of ACIU shares. iShares Biotechnology ETF is the top mutual fund, with 0.48% of its assets in AC Immune shares.
ACIU Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | AC Immune | 24.47% | 38.09% | 37.43% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 19.82M | 20.09% | $47.18M |
| Blackrock | 2.61M | 2.62% | $10.40M |
| Wells fargo & company/mn | 1.00M | 1.02% | $2.39M |
| Renaissance | 843.17K | 0.85% | $2.21M |
| Millennium management | 773.59K | 0.78% | $1.84M |
| Blackrock funding, inc. /de | 562.38K | 0.57% | $1.47M |
| Dimensional fund advisors lp | 349.35K | 0.35% | $915.10K |
| Arrowstreet capital, limited partnership | 225.07K | 0.23% | $589.70K |
| Citadel advisors | 207.61K | 0.21% | $494.10K |
| Two sigma investments, lp | 102.83K | 0.10% | $244.72K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bvf inc/il | 19.82M | 1.21% | $47.18M |
| Verdad advisers, lp | 16.30K | 0.04% | $38.79K |
| Silverberg bernstein capital management | 10.00K | 0.01% | $23.80K |
| Renaissance | 843.17K | 0.00% | $2.21M |
| China universal asset management | 18.57K | 0.00% | $48.28K |
| Quinn opportunity partners | 10.10K | 0.00% | $26.46K |
| Millennium management | 773.59K | 0.00% | $1.84M |
| Banque cantonale vaudoise | 7.02K | 0.00% | $18.00K |
| Activest wealth management | 1.00K | 0.00% | $2.38K |
| Wells fargo & company/mn | 1.00M | 0.00% | $2.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.61M | 0.00% | 65.48K |
| Two sigma investments, lp | 102.83K | 0.00% | 63.73K |
| Blackrock funding, inc. /de | 562.38K | - | 43.10K |
| Nomura | 20.00K | 0.00% | 20.00K |
| Marshall wace, llp | 18.46K | - | 18.46K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Redmile group | - | - | -1.03M |
| Avidity partners management lp | - | - | -825.00K |
| Platinum investment management | - | - | -739.34K |
| Point72 asset management | - | - | -384.85K |
| Northern trust | - | - | -278.51K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nomura | 20.00K | 0.00% | 20.00K | $79.80K |
| Private advisor group | 16.60K | 0.00% | 16.60K | $47.97M |
| Verdad advisers, lp | 16.30K | 0.04% | 16.30K | $38.79K |
| Sg americas securities | 10.33K | - | 10.33K | $25.00K |
Sold Out
| Holder | Change |
|---|---|
| Sjs investment consulting | -200.00 |
| Lazard asset management | -813.00 |
| Pnc financial services group | -1.00K |
| Forum finance group | -2.00K |
| Zurcher kantonalbank (zurich cantonalbank) | -3.12K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 41 | -12.77% | 24,149,924 | -1.31% | 24 | 3.98% | 17 | - | 13 | -13.33% |
| Jun 30, 2026 | 47 | -7.84% | 24,469,719 | -2.43% | 24 | 3.84% | 17 | -22.73% | 15 | -11.76% |
| Mar 31, 2026 | 29 | -38.30% | 3,698,006 | -85.65% | 3 | 0.54% | 16 | -23.81% | 9 | -18.18% |
| Dec 31, 2025 | 31 | -26.19% | 3,889,775 | -84.20% | 3 | 0.66% | 13 | -35.00% | 9 | -18.18% |
| Sep 30, 2025 | 42 | 13.51% | 24,624,045 | 1.47% | 24 | 4.19% | 20 | 17.65% | 11 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Biotechnology ETF | 477.71K | 0.48% | -906.00 |
| BlackRock Health Sciences Term Trust | 258.71K | 0.26% | -370.12K |
| DWS ESG Biotech LC | 253.39K | 0.25% | - |
| BlackRock Health Sciences Opps Inv A | 115.87K | 0.12% | -242.44K |
| Monega ARIAD Innovation R | 92.36K | 0.09% | - |
| iShares Nasdaq US Biotech ETF USD Acc | 83.85K | 0.08% | 174.00 |
| Dimensional US Small Cap ETF | 80.74K | 0.08% | - |
| ALPS Medical Breakthroughs ETF | 79.77K | 0.08% | 628.00 |
| Fidelity Nasdaq Composite Index | 69.85K | 0.07% | - |
| Blackrock Health Sciences Trust | 62.90K | 0.06% | -15.28K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 15, 2026 | Pfeifer Andrea | Chief Executive Officer | Sell | $27.93K |
| Apr 15, 2026 | Pfeifer Andrea | Chief Executive Officer | Sell | $31.43K |
| Apr 15, 2026 | Pfeifer Andrea | Chief Executive Officer | Sell | $31.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q2 | 1 | 2 |
| 2026 Q1 | - | - |
ACIU Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools